NK cells in the eye

Natural Killer Cells

Volumn , Issue , 2010, Pages 385-401

  Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874128600     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-370454-2.00029-6     Document Type: Chapter

References (162)

1. Alizadeh H., Howard K., Mellon J., Mayhew E., Rusciano D., Niederkorn J.Y. Reduction of liver metastasis of intraocular melanoma by interferon-beta gene transfer. Invest Ophthalmol Vis Sci 2003, 44:3042-3051.
2. Anastassiou G., Coupland S.E., Stang A., Boeloeni R., Schilling H., Bornfeld N. Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value. J Pathol 2001, 194:466-472.
3. Apte R.S., Niederkorn J.Y. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol 1996, 156:2667-2673.
4. Apte R.S., Mayhew E., Niederkorn J.Y. Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Invest Ophthalmol Vis Sci 1997, 38:1277-1282.
5. Apte R.S., Sinha D., Mayhew E., Wistow G.J., Niederkorn J.Y. Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 1998, 160:5693-5696.
6. Babu J.S., Kanangat S., Rouse B.T. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J Immunol 1995, 154:4822-4829.
7. Barker C.F., Billingham R.E. The role of afferent lymphatics in the rejection of skin homografts. J Exp Med 1968, 128:197-221.
8. Bellinger D.L., Lorton D., Romano T.D., Olschowka J.A., Felten S.Y., Felten D.L. Neuropeptide innervation of lymphoid organs. Ann N Y Acad Sci 1990, 594:17-33.
9. Beutelspacher S.C., Pillai R., Watson M.P., Tan P.H., Tsang J., McClure M.O., George A.J., Larkin D.F. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 2006, 36:690-700.
10. Blom D.J., Luyten G.P., Mooy C., Kerkvliet S., Zwinderman A.H., Jager M.J. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma. Invest Ophthalmol Vis Sci 1997, 38:1865-1872.
11. Blom D.J., Schurmans L.R., De Waard-Siebinga I., De Wolff-Rouendaal D., Keunen J.E., Jager M.J. HLA expression in a primary uveal melanoma, its cell line, and four of its metastases. Br J Ophthalmol 1997, 81:989-993.
12. Bouley D.M., Kanangat S., Rouse B.T. The role of the innate immune system in the reconstituted SCID mouse model of herpetic stromal keratitis. Clin Immunol Immunopathol 1996, 80:23-30.
13. Brandt C.R., Salkowski C.A. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1. Invest Ophthalmol Vis Sci 1992, 33:113-120.
14. Brocker E.B., Suter L., Bruggen J., Ruiter D.J., Macher E., Sorg C. Phenotypic dynamics of tumor progression in human malignant melanoma. Int J Cancer 1985, 36:29-35.
15. Brossay L., Chioda M., Burdin N., Koezuka Y., Casorati G., Dellabona P., Kronenberg M. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 1998, 188:1521-1528.
16. Caspi R.R., Silver P.B., Luger D., Tang J., Cortes L.M., Pennesi G., Mattapallil M.J., Chan C.C. Mouse models of experimental autoimmune uveitis. Ophthalmic Res 2008, 40:169-174.
17. Char D.H. Metastatic choroidal melanoma. Am J Ophthalmol 1978, 86:76-80.
18. Chen H., Paul W.E. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J Immunol 1997, 159:2240-2249.
19. Claerhout I., Kestelyn P., Debacker V., Beele H., Leclercq G. Role of natural killer cells in the rejection process of corneal allografts in rats. Transplantation 2004, 77:676-682.
20. Cousins S.W., McCabe M.M., Danielpour D., Streilein J.W. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991, 32:2201-2211.
21. Cox C.A., Shi G.P., Yin H., Vistica B.P., Wawrousek E.F., Chan C.C., Gery I. Both Th1 and Th17 are immunopathogenic but differ in other key biologic activities. J Immunol 2008, 180:7414-7422.
22. D'Orazio T.J., Niederkorn J.Y. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol 1998, 160:2089-2098.
23. D'Orazio T.J., DeMarco B.M., Mayhew E.S., Niederkorn J.Y. Effect of aqueous humor on apoptosis of inflammatory cell types. Invest Ophthalmol Vis Sci 1999, 40:1418-1426.
24. Dawson C.R. Ocular herpes simplex virus infections. Clin Dermatol 1984, 2:56-66.
25. de la Cruz P.O., Specht C.S., McLean I.W. Lymphocytic infiltration in uveal malignant melanoma. Cancer 1990, 65:112-115.
26. de Waard-Siebinga I., Hilders C.G., Hansen B.E., van Delft J.L., Jager M.J. HLA expression and tumor-infiltrating immune cells in uveal melanoma. Graefes Arch Clin Exp Ophthalmol 1996, 234:34-42.
27. Della Chiesa M., Carlomagno S., Frumento G., Balsamo M., Cantoni C., Conte R., Moretta L., Moretta A., Vitale M. The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46-and NKG2D-activating receptors and regulates NK-cell function. Blood 2006, 108:4118-4125.
28. Dithmar S.A., Rusciano D.A., Armstrong C.A., Lynn M.J., Grossniklaus H.E. Depletion of NK cell activity results in growth of hepatic micrometastases in a murine ocular melanoma model. Curr Eye Res 1999, 19:426-431.
29. Dithmar S., Rusciano D., Lynn M.J., Lawson D.H., Armstrong C.A., Grossniklaus H.E. Neoadjuvant interferon alfa-2b treatment in a murine model for metastatic ocular melanoma: a preliminary study. Arch Ophthalmol 2000, 118:1085-1089.
30. Dong Z., Greene G., Pettaway C., Dinney C.P., Eue I., Lu W., Bucana C.D., Balbay M.D., Bielenberg D., Fidler I.J. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Cancer Res 1999, 59:872-879.
31. Donoso L.A., Berd D., Augsburger J.J., Mastrangelo M.J., Shields J.A. Metastatic uveal melanoma. Pretherapy serum liver enzyme and liver scan abnormalities. Arch Ophthalmol 1985, 103:796-798.
32. Doymaz M.Z., Rouse B.T. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. Invest Ophthalmol Vis Sci 1992, 33:2165-2173.
33. Durie F.H., Campbell A.M., Lee W.R., Damato B.E. Analysis of lymphocytic infiltration in uveal melanoma. Invest Ophthalmol Vis Sci 1990, 31:2106-2110.
34. Eberl G., MacDonald H.R. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 2000, 30:985-992.
35. Ericsson C., Seregard S., Bartolazzi A., Levitskaya E., Ferrone S., Kiessling R., Larsson O. Association of HLA class I and class II antigen expression and mortality in uveal melanoma. Invest Ophthalmol Vis Sci 2001, 42:2153-2156.
36. Esser P., Grisanti S., Bartz-Schmidt K. TGF-beta in uveal melanoma. Microsc Res Tech 2001, 52:396-400.
37. Faunce D.E., Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 2002, 169:31-38.
38. Faunce D.E., Sonoda K.H., Stein-Streilein J. MIP-2 recruits NKT cells to the spleen during tolerance induction. J Immunol 2001, 166:313-321.
39. Ferrone S., Marincola F.M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995, 16:487-494.
40. Figueiredo F., Commodaro A.G., de Camargo M.M., Rizzo L.V., Belfort R. NK1.1 cells downregulate murine endotoxin-induced uveitis following intraocular administration of interleukin-12. Scand J Immunol 2007, 66:329-334.
41. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., Horton H.F., Fouser L., Carter L., Ling V., Bowman M.R., Carreno B.M., Collins M., Wood C.R., Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000, 192:1027-1034.
42. Frumento G., Rotondo R., Tonetti M., Damonte G., Benatti U., Ferrara G.B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 2002, 196:459-468.
43. Gery I., Nussenblatt R.B., Chan C.C., Caspi R.R. Autoimmune diseases of the eye. The Molecular Pathology of Autoimmune Diseases 2002, 978-998. Taylor and Francis, New York. A.N. Theofilipoulous, C.A. Bona (Eds.).
44. Ghiasi H., Cai S., Perng G.C., Nesburn A.B., Wechsler S.L. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral Res 2000, 45:33-45.
45. Godfrey D.I., Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004, 114:1379-1388.
46. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., Baxter A.G. NKT cells: facts, functions and fallacies. Immunol Today 2000, 21:573-583.
47. Goslings W.R., Prodeus A.P., Streilein J.W., Carroll M.C., Jager M.J., Taylor A.W. A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation. Invest Ophthalmol Vis Sci 1998, 39:989-995.
48. Granstein R.D., Staszewski R., Knisely T.L., Zeira E., Nazareno R., Latina M., Albert D.M. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J Immunol 1990, 144:3021-3027.
49. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995, 270:1189-1192.
50. Hazlett L.D. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res 2004, 23:1-30.
51. Hazlett L.D., McClellan S., Kwon B., Barrett R. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive. Invest Ophthalmol Vis Sci 2000, 41:805-810.
52. Hazlett L.D., Qianqian L., Liu J., McClellan S., Du W., Barrett R.P. NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptible mice. J Immunol 2007, 179:1138-1146.
53. He Y.G., Mayhew E., Mellon J., Niederkorn J.Y. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells. Invest Ophthalmol Vis Sci 2004, 45:4240-4246.
54. Hegde S., Beauregard C., Mayhew E., Niederkorn J.Y. CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis. Transplantation 2005, 79:23-31.
55. Hendricks R.L., Tumpey T.M., Finnegan A. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J Immunol 1992, 149:3023-3028.
56. Hicklin D.J., Marincola F.M., Ferrone S. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today 1999, 5:178-186.
57. Ho L.P., Urban B.C., Jones L., Ogg G.S., McMichael A.J. CD4(-)CD8alphaalpha subset of CD1d-restricted NKT cells controls T cell expansion. J Immunol 2004, 172:7350-7358.
58. Hori J., Wang M., Miyashita M., Tanemoto K., Takahashi H., Takemori T., Okumura K., Yagita H., Azuma M. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol 2006, 177:5928-5935.
59. Jager M.J., Hurks H.M.H., Levitskaya J., Kiessling R. HLA expressin in uveal melanoma: there is no rule without some exception. Hum Immunol 2002, 63:444-451.
60. Jampel H.D., Roche N., Stark W.J., Roberts A.B. Transforming growth factor-beta in human aqueous humor. Curr Eye Res 1990, 9:963-969.
61. Kageshita T., Hirai S., Ono T., Hicklin D.J., Ferrone S. Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. Am J Pathol 1999, 154:745-754.
62. Katagiri K., Zhang-Hoover J., Mo J.S., Stein-Streilein J., Streilein J.W. Using tolerance induced via the anterior chamber of the eye to inhibit Th2-dependent pulmonary pathology. J Immunol 2002, 169:84-89.
63. Kitaichi N., Kotake S., Morohashi T., Onoe K., Ohno S., Taylor A.W. Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells. J Leukoc Biol 2002, 72:1117-1121.
64. Kogiso M., Tanouchi Y., Mimura Y., Nagasawa H., Himeno K. Endotoxin-induced uveitis in mice. 1. Induction of uveitis and role of T lymphocytes. Jpn J Ophthalmol 1992, 36:281-290.
65. Kosiewicz M.M., Alard P., Streilein J.W. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production. J Immunol 1998, 161:5382-5390.
66. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248:220-223.
67. Krueger J.G., Krane J.F., Carter D.M., Gottlieb A.B. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 1990, 94:135S-140S.
68. Ksander B.R., Rubsamen P.E., Olsen K.R., Cousins S.W., Streilein J.W. Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma. Invest Ophthalmol Vis Sci 1991, 32:3198-3208.
69. Lass J.H., Walter E.I., Burris T.E., Grossniklaus H.E., Roat M.I., Skelnik D.L., Needham L., Singer M., Medof M.E. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci 1990, 31:1136-1148.
70. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., Greenfield E.A., Bourque K., Boussiotis V.A., Carter L.L., Carreno B.M., Malenkovich N., Nishimura H., Okazaki T., Honjo T., Sharpe A.H., Freeman G.J. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001, 2:261-268.
71. LeBouteiller P. HLA class I chromosomal region, genes, and products: facts and questions. Crit Rev Immunol 1994, 14:89-129.
72. Le Discorde M., Moreau P., Sabatier P., Legeais J.M., Carosella E.D. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 2003, 64:1039-1044.
73. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 1998, 95:5199-5204.
74. Li X., Taylor S., Zegarelli B., Shen S., O'Rourke J., Cone R.E. The induction of splenic suppressor T cells through an immune-privileged site requires an intact sympathetic nervous system. J Neuroimmunol 2004, 153:40-49.
75. Li Z., Lim W.K., Mahesh S.P., Liu B., Nussenblatt R.B. Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. J Immunol 2005, 174:5187-5191.
76. Lighvani S., Huang X., Trivedi P.P., Swanborg R.H., Hazlett L.D. Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection. Eur J Immunol 2005, 35:1567-1575.
77. Ljunggren H.G., Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990, 11:237-244.
78. Ljunggren H.G., Ohlen C., Hoglund P., Franksson L., Karre K. The RMA-S lymphoma mutant; consequences of a peptide loading defect on immunological recognition and graft rejection. Int J Cancer Suppl 1991, 6:38-44.
79. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., Bowman E.P., Sgambellone N.M., Chan C.C., Caspi R.R. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810.
80. Ma D., Niederkorn J.Y. Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis. Immunology 1995, 86:263-269.
81. Ma D., Luyten G.P., Luider T.M., Niederkorn J.Y. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci 1995, 36:435-441.
82. Madden K.S., Felten S.Y., Felten D.L., Sundaresan P.R., Livnat S. Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and vitro following chemical sympathectomy. Brain Behav Immun 1989, 3:72-89.
83. Marriott I., Bost K.L. Substance P receptor mediated macrophage responses. Adv Exp Med Biol 2001, 493:247-254.
84. Medawar P.B. A second study of the behavior and fate of skin homografts in rabbits. J Anat 1945, 79:157-176.
85. Medawar P.B. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948, 29:58-69.
86. Meecham W.J., Char D.H., Kaleta-Michaels S. Infiltrating lymphocytes and antigen expression in uveal melanoma. Ophthalmic Res 1992, 24:20-26.
87. Mercadal C.M., Bouley D.M., DeStephano D., Rouse B.T. Herpetic stromal keratitis in the reconstituted scid mouse model. J Virol 1993, 67:3404-3408.
88. Metcalf J.F., Hamilton D.S., Reichert R.W. Herpetic keratitis in athymic (nude) mice. Infect Immun 1979, 26:1164-1171.
89. Miller D. Ophthalmology. The Essentials 1979, Houghton Mifflin Professional Publishers, Boston.
90. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002, 2:656-663.
91. Mooy C.M., De Jong P.T. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol 1996, 41:215-228.
92. Nakamura T., Sonoda K.H., Faunce D.E., Gumperz J., Yamamura T., Miyake S., Stein-Streilein J. CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol 2003, 171:1266-1271.
93. Nakamura T., Terajewicz A., Stein-Streilein J. Mechanisms of peripheral tolerance following intracameral inoculation are independent of IL-13 or STAT6. J Immunol 2005, 175:2643-2646.
94. Naumov Y.N., Bahjat K.S., Gausling R., Abraham R., Exley M.A., Koezuka Y., Balk S.B., Strominger J.L., Clare-Salzer M., Wilson S.B. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci U S A 2001, 98:13838-13843.
95. Navarro F., Llano M., Bellon T., Colonna M., Geraghty D.E., Lopez-Botet M. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999, 29:277-283.
96. Niederkorn J.Y. Immunopathogenesis of intraocular tumors. Prog Retin Eye Res 1995, 14:505-526.
97. Niederkorn J.Y. The immune privilege of corneal allografts. Transplantation 1999, 67:1503-1508.
98. Niederkorn J.Y. Immune privilege in the anterior chamber of the eye. Crit Rev Immunol 2002, 22:13-46.
99. Niederkorn J.Y. The immune privilege of corneal grafts. J Leukoc Biol 2003, 74:167-171.
100. Niederkorn J.Y. Anterior chamber-associated immune deviation and its impact on corneal allograft survival. Curr Opin Organ Transplant 2006, 11:360-365.
101. Niederkorn J.Y. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 2006, 7:354-359.
102. Niederkorn J.Y. Immune mechanisms of corneal allograft rejection. Curr Eye Res 2007, 32:1005-1016.
103. Niederkorn J.Y. The induction of anterior chamber-associated immune deviation. Chem Immunol Allergy 2007, 92:27-35.
104. Niederkorn J.Y., Wang S. Immune privilege of the eye and fetus: parallel universes?. Transplantation 2005, 80:1139-1144.
105. Niederkorn J.Y., Wang S. Immunology of intraocular tumors. Ocul Immunol Inflamm 2005, 13:105-110.
106. Niederkorn J.Y., Mayhew E., He Y. Alloantigens introduced into the anterior chamber of the eye induce systemic suppression of delayed hypersensitivity to third-party alloantigens through "linked recognition". Transplantation 1995, 60:348-354.
107. Niederkorn J.Y., Chiang E.Y., Ungchusri T., Stroynowski I. Expression of a nonclassical MHC class Ib molecule in the eye. Transplantation 1999, 68:1790-1799.
108. Niemialtowski M.G., Rouse B.T. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol 1992, 149:3035-3039.
109. Nitta T., Oksenberg J.R., Rao N.A., Steinman L. Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma. Science 1990, 249:672-674.
110. Oakes J.E., Monteiro C.A., Cubitt C.L., Lausch R.N. Induction of interleukin-8 gene expression is associated with herpes simplex virus infection of human corneal keratocytes but not human corneal epithelial cells. J Virol 1993, 67:4777-4784.
111. Okazaki T., Honjo T. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 2007, 19:813-824.
112. Okumura A., Mochizuki M., Nishi M., Herbort C.P. Endotoxin-induced uveitis (EIU) in the rat: a study of inflammatory and immunological mechanisms. Int Ophthalmol 1990, 14:31-36.
113. Orcel P., BielakoffJ., De Vernejoul M.C. Effects of transforming growth factor-beta on long-term human cord blood monocyte cultures. J Cell Physiol 1990, 142:293-298.
114. Peng Y., Han G., Shao H., Wang Y., Kaplan H.J., Sun D. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 2007, 48:4153-4161.
115. Rajpal S., Moore R., Karakousis C.P. Survival in metastatic ocular melanoma. Cancer 1983, 52:334-336.
116. Repp A.C., Mayhew E.S., Apte S., Niederkorn J.Y. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol 2000, 165:710-715.
117. Rice P.A., Boehm G.W., Moynihan J.A., Bellinger D.L., Stevens S.Y. Chemical sympathectomy increases the innate immune response and decreases the specific immune response in the spleen to infection with Listeria monocytogenes. J Neuroimmunol 2001, 114:19-27.
118. Rook A.H., Kehrl J.H., Wakefield L.M., Roberts A.B., Sporn M.B., Burlington D.B., Lane H.C., Fauci A.S. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 1986, 136:3916-3920.
119. Rook G.A., Lightman S.L., Heijnen C.J. Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. Trends Immunol 2002, 23:18-22.
120. Rosenbaum J.T., McDevitt H.O., Guss R.B., Egbert P.R. Endotoxin-induced uveitis in rats as a model for human disease. Nature 1980, 286:611-613.
121. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997, 94:11520-11525.
122. Ruiter D.J., Bhan A.K., Harrist T.J., Sober A.J., Mihm M.C. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. J Immunol 1982, 129:2808-2815.
123. Ruiter D.J., Bergman W., Welvaart K., Scheffer E., van Vloten W.A., Russo C., Ferrone S. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens. Cancer Res 1984, 44:3930-3935.
124. Ruiter D.J., Mattijssen V., Broecker E.B., Ferrone S. MHC antigens in human melanomas. Semin Cancer Biol 1991, 2:35-45.
125. Russell R.G., Nasisse M.P., Larsen H.S., Rouse B.T. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest Ophthalmol Vis Sci 1984, 25:938-944.
126. Ryu Y.H., Kim J.C. Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor. Invest Ophthalmol Vis Sci 2007, 48:4148-4152.
127. Shao H., Van Kaer L., Sun S.L., Kaplan H.J., Sun D. Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis. J Autoimmun 2003, 21:37-45.
128. She S.C., Steahly L.P., Moticka E.J. Intracameral injection of allogeneic lymphocytes enhances corneal graft survival. Invest Ophthalmol Vis Sci 1990, 31:1950-1956.
129. Shen L., Jin Y., Freeman G.J., Sharpe A.H., Dana M.R. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J Immunol 2007, 179:3672-3679.
130. Sohn J.H., Kaplan H.J., Suk H.J., Bora P.S., Bora N.S. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest Ophthalmol Vis Sci 2000, 41:3492-3502.
131. Sohn J.H., Kaplan H.J., Suk H.J., Bora P.S., Bora N.S. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest Ophthalmol Vis Sci 2000, 41:4195-4202.
132. Sonoda K.H., Stein-Streilein J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J Immunol 2002, 32:848-857.
133. Sonoda K.H., Faunce D.E., Taniguchi M., Exley M., Balk S., Stein-Streilein J. NK T cell-derived IL-10 is essential for the differentiation of antigen- specific T regulatory cells in systemic tolerance. J Immunol 2001, 166:42-50.
134. Sonoda K.H., Taniguchi M., Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d- reactive NKT cells. J Immunol 2002, 168:2028-2034.
135. Staibano S., Mascolo M., Tranfa F., Salvatore G., Mignogna C., Bufo P., Nugnes L., Bonavolonta G., De Rosa G. Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior?. Int J Immunopathol Pharmacol 2006, 19:171-179.
136. Streilein J.W. Immune regulation and the eye: a dangerous compromise. FASEB J 1987, 1:199-208.
137. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003, 3:879-889.
138. Streilein J.W., Dana M.R., Ksander B.R. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today 1997, 18:443-449.
139. Streilein J.W., Takeuchi M., Taylor A.W. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Hum Immunol 1997, 52:138-143.
140. Streilein J.W., Masli S., Takeuchi M., Kezuka T. The eye's view of antigen presentation. Hum Immunol 2002, 63:435-443.
141. Stuart P.M., Griffith T.S., Usui N., Pepose J., Yu X., Ferguson T.A. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997, 99:396-402.
142. Tamesis R.R., Messmer E.M., Rice B.A., Dutt J.E., Foster C.S. The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice. Eye 1994, 8(Pt 3):298-306.
143. Taylor A.W. Ocular immunosuppressive microenvironment. Chem Immunol 2007, 92:71-85.
144. Taylor A.W., Yee D.G. Somatostatin is an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 2003, 44:2644-2649.
145. Taylor A.W., Streilein J.W., Cousins S.W. Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation 1994, 1:188-194.
146. Taylor A.W., Streilein J.W., Cousins S.W. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol 1994, 153:1080-1086.
147. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 2001, 193:839-846.
148. van Dooremaal J.C. Die Entwicklung der in fremden Grund versetzten lebenden Geweba. Albrecht von Graefes Arch Ophthalmol 1873, 19:358-373.
149. van Duinen S.G., Ruiter D.J., Broecker E.B., van der Velde E.A., Sorg C., Welvaart K., Ferrone S. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res 1988, 48:1019-1025.
150. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992, 10:411-452.
151. Verbik D.J., Murray T.G., Tran J.M., Ksander B.R. Melanomas that develop within the eye inhibit lymphocyte proliferation. Int J Cancer 1997, 73:470-478.
152. Vijayasaradhi S., Houghton A.N. Melanoma and melanocytes: pigmentation, tumor progression, and the immune response to cancer. Adv Pharmacol 1995, 32:343-374.
153. Wacker W.B., Lipton M.M. Experimental allergic uveitis: homologous retina as uveitogenic antigen. Nature 1965, 206:253-254.
154. Wang Y., Goldschneider I., Foss D., Wu D.Y., O'Rourke J., Cone R.E. Direct thymic involvement in anterior chamber-associated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice. J Immunol 1997, 158:2150-2155.
155. Wang Y., Goldschneider I., O'Rourke J., Cone R.E. Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation. J Leukoc Biol 2001, 69:741-746.
156. Watte C.M., Nakamura T., Lau C.H., Ortaldo J.R., Stein-Streilein J. Ly49 C/I-dependent NKT cell-derived IL-10 is required for corneal graft survival and peripheral tolerance. J Leukoc Biol 2008, 83:928-935.
157. Wax M.B., Tezel G., Yang J., Peng G., Patil R.V., Agarwal N., Sappington R.M., Calkins D.J. Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. J Neurosci 2008, 28:12085-12096.
158. Yamagami S., Kawashima H., Tsuru T., Yamagami H., Kayagaki N., Yagita H., Okumura K., Gregerson D.S. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 1997, 64:1107-1111.
159. Yang W., Li H., Chen P.W., Alizadeh H., He Y.-G., Hogan R.N., Niederkorn J.Y. PD-L1 expession on human ocular cells and its possible role in regulating immune-mediated ocular inflammation. Invest Ophthalmol Vis Sci 2009, 50:273-280.
160. Yoshimura T., Sonoda K.H., Miyazaki Y., Iwakura Y., Ishibashi T., Yoshimura A., Yoshida H. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol 2008, 20:209-214.
161. Zhang Y., Ramos B.F., Jakschik B.A. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992, 258:1957-1959.
162. Zirm E. Eine erfolgreiche totale Keratoplastik. Albrecht von Graefes Arch Ophthalmol 1906, 64:580-593.